Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes

Virology Journal

Volumn 7, Issue , 2010, Pages

  Tan, Lei ^a,b   Lu, Huijun ^b   Zhang, Dan ^a,b   Tian, Mingyao ^a,b   Hu, Bo ^a,b   Wang, Zhuoyue ^a,b   Jin, Ningyi ^b  

^a JILIN UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE; GAMMA INTERFERON; INFLUENZA VACCINE; PLASMID DNA; VIRUS HEMAGGLUTININ; EPITOPE; HLA ANTIGEN CLASS 2; INFLUENZA VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE REGIMEN; FEMALE; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INTERFERON PRODUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SURVIVAL RATE; TH2 CELL; VIRUS TITRATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BIOLOGY; CELL LINE; HAMSTER; IMMUNOLOGY; MOLECULAR GENETICS; ORTHOMYXOVIRUS INFECTION;

AVIAN INFLUENZA VIRUS; MUS; ORTHOMYXOVIRIDAE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; COMPUTATIONAL BIOLOGY; CRICETINAE; EPITOPES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, DNA;

EID: 78649734755     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-363     Document Type: Article

References (24)

1. Pandemic Influenza (H1N1) 2009 Is Associated with Severe Disease in India. Akhilesh C Mishra Mandeep S Chadha Manohar L Choudhary VA Potdar, PLoS One 2010 5 10540 10.1371/journal.pone.0010540 20479875
2. Influenza vaccines. AH Ellebedy RJ Webby, Vaccine 2009 27 65 D68 10.1016/j.vaccine.2009.08.038 19837290
3. Nucleic acid sequence-based amplification methods to detect avian influenza virus. LT Lau J Banks R Aherne IH Brown N Dillon RA Collins KY Chan YW Fung J Xing Y AC, Biochem Biophys Res Commun 2004 313 336 342 10.1016/j.bbrc.2003.11.131 14684165
4. Homologous recombination as an evolutionary force in the avian influenza A virus. CQ He ZX Xie GZ Han JB Dong D Wang JB Liu LY Ma XF Tang XP Liu YS Pang L GR, Mol Biol Evol 2009 26 177 187 10.1093/molbev/msn238 18931384
5. Origin and evolution of highly pathogenic H5N1 avian influenza in Asia. LD Sims J Domenech C Benigno S Kahn A Kamata J Lubroth V Martin R P, Vet Rec 2005 157 159 164 16085721
6. Design of peptide and polypeptide vaccines. T Ben-Yedidia A R, Curr Opin Biotechnol 1997 8 442 448 10.1016/S0958-1669(97)80066-3 9265723
7. Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21. O Kashala R Amador MV Valero A Moreno A Barbosa B Nickel CA Daubenberger F Guzman G Pluschke P ME, Vaccine 2002 20 2263 2277 10.1016/S0264-410X(02)00115-9 12009282
8. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. EH Nardin GA Oliveira JM Calvo-Calle ZR Castro RS Nussenzweig B Schmeckpeper BF Hall C Diggs S Bodison E R, J Infect Dis 2000 182 1486 1496 10.1086/315871 11023472
9. Peptide vaccines against hepatitis B virus: from animal model to human studies. OB Engler WJ Dai A Sette IP Hunziker J Reichen WJ Pichler C A, Mol Immunol 2001 38 457 465 10.1016/S0161-5890(01)00081-5 11741695
10. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine. H Gahery N Daniel B Charmeteau L Ourth A Jackson M Andrieu J Choppin D Salmon G Pialoux G JG, AIDS Res Hum Retroviruses 2006 22 684 694 10.1089/aid.2006.22.684 16831093
11. HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIVinfected patients. LA Pinto JA Berzofsky KR Fowke RF Little F Merced-Galindez R Humphrey J Ahlers N Dunlop RB Cohen SM Steinberg,, et al. AIDS 1999 13 2003 2012 10.1097/00002030-199910220-00002 10546852
12. A universal epitope-based influenza vaccine and its efficacy against H5N1. Y Adar Y Singer R Levi E Tzehoval S Perk C Banet-Noach S Nagar R Arnon T B-Y, Vaccine 2009 27 2099 2107 10.1016/j.vaccine.2009.02.011 19356612
13. Epitope analysis for influenza vaccine design. ET Mũoz D MW, Vaccine 2005 23 1144 1148 15629357
14. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. JW Zinckgraf M Sposato V Zielinski D Powell JJ Treanor vH E, Vaccine 2009 27 5393 5401 10.1016/j.vaccine.2009.06.081 19596415
15. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. AS De Groot M Ardito EM McClaine L Moise M WD, Vaccine 2009 27 5740 5747 10.1016/j.vaccine.2009.07.040 19660593
16. The effect of amino acid spacers on the antigenicity of dimeric peptide - inducing cross-reacting antibodies to a cell surface protein antigen of Streptococcus mutans. Y Oishi A Onozuka H Kato N Shimura S Imai N T, Oral Microbiol Immunol 2001 16 40 44 10.1034/j.1399-302x.2001.160107.x 11169138
17. An ingenious design for peptide vaccines. A Yano A Onozuka Y Asahi-Ozaki S Imai N Hanada Y Miwa N T, Vaccine 2005 23 2322 2326 10.1016/j.vaccine.2005.01. 031 15755620
18. Influenza: propagation, quantification, and storage. KJ Szretter AL Balish K JM, Curr Protoc Microbiol 2006 Chapter 15 Unit 15G.11 18770580
19. A simple method of estimating fifty percent endpoints. LJ Reed M H, AMERICAN JOURNAL OF HYGIENE 1938 27 493 497
20. Multiple roles of the invariant chain in MHC class II function. P Stumptner-Cuvelette B P, Biochim Biophys Acta 2002 1542 1 13 10.1016/S0167-4889(01)00166-5 11853874
21. Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential. R Parida MS Shaila S Mukherjee NR Chandra N R, Vaccine 2007 25 7530 7539 10.1016/j.vaccine.2007.08.044 17900763
22. Paradoxical roles of IFN- in models of Th1-mediated autoimmunity. Edward F Rosloniec Latham Kary YB Guedez, Arthritis Res 2002 4 333 336 10.1186/ar432 12453308
23. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. K Moro T Yamada M Tanabe T Takeuchi T Ikawa H Kawamoto J Furusawa M Ohtani H Fujii K S, Nature 2009 463 540 544 10.1038/nature08636 20023630
24. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. JB Ulmer RR Deck CM DeWitt A Friedman JJ Donnelly L MA, vaccine 1994 12 1541 1544 10.1016/0264-410X(94)90081-7 7879422